Navigation Links
The use of placebo in rheumatoid arthritis clinical trials may negatively impact patients
Date:5/27/2011

The results of this study, conducted in Germany, re-open the debate on whether it is ethical to conduct placebo-controlled studies where patients in the placebo-group are at a serious disadvantage compared to patients taking the new treatments. The study analysed current study designs, for new therapies such as abatacept (Orencia), golimumab (Simponi) or tocilizumab (Actemra), and showed that patients in the placebo group experienced no change in medication, having to continue with their former, ineffective treatment plus placebo.

"According to the Helsinki-Declaration of the World Medical Association*, a placebo-controlled study design is deemed to be ethically acceptable when there is no other effective treatment," said Dr. Juche, Johanniter-Hospital, Treuenbrietzen, Germany. "However, this analysis confirms that patients in the placebo-group are at a disadvantage as they are given no change in medication to reduce their active inflammatory condition or halt disease progression. Our recommendation is that future clinical trials should include an active comparator group to ensure that all patients receive effective treatments to improve their quality of life."

In the analysis, researchers used studies from the European Public Assessment Report (EPAR) of the European Medicines Agency (EMA) for abatacept, golimumab and tocilizumab as samples. The studies chosen had to be placebo controlled at the beginning and state clinical relevant outcome criteria (e.g. DAS28**, ACR20***, Health Assessment Questionnaire and joint erosion scores).


'/>"/>

Contact: Rory Berrie
rory.berrie@cohnwolfe.com
44-790-151-3297
European League Against Rheumatism
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. Goji berries have the same nutrients as fruits and vegetables and a placebo effect
2. New therapeutic target identified for rheumatoid arthritis
3. Anakinra for rheumatoid arthritis: A modest benefit with some risk
4. Gene therapy demonstrates benefit in patients with rheumatoid arthritis
5. Researchers identify new risk factor gene for rheumatoid arthritis
6. New trigger for chronic inflammation in rheumatoid arthritis discovered
7. BUSPH study links rheumatoid arthritis to vitamin D deficiency
8. Study confirms link between rheumatoid arthritis and COPD
9. Undertreatment of cardiovascular disease in rheumatoid arthritis patients following a heart attack
10. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
11. Inhibiting proteins may prevent cartilage breakdown in arthritis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... BOSTON , June 17, 2013 ... prolific, the need to secure them grows exponentially, ... the latest report from Heavy Reading Insider ... from Heavy Reading ( www.heavyreading.com ). ... Smartphones examines the market for biometric authentication on ...
(Date:6/17/2013)... the topics under discussion during the E3 Forum, ... consecutive year, this will be a unique event ... members of Academy, Business, Educators, Entrepreneurs, Innovators, Policy-makers ... Martn Garijo (IBM South Europe), Chris Zegras (MIT), ... (Hovione), among others. E3 Forum - Education, Employment ...
(Date:6/16/2013)... 16, 2013)Male mice who were fed a high-fat diet ... who also had higher levels of body fat, a ... observed primarily in male offspring, despite their consumption of ... meeting of The Endocrine Society in San Francisco, Calif. ... affect metabolism and behavior of offspring dependent on the ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2Obese male mice father offspring with higher levels of body fat 2
... Trust researchers have identified a key gene involved in the ... mostly women. The lead researcher behind the study has called ... to further study the underlying causes of the disease. ... autoimmune disease which frequently causes skin rash, joint pains and ...
... to differentiate metastatic cancer cells from normal cells in ... of the cells. The study, published Dec. 2, ... Nature Nanotechnology, represents one of the first times researchers ... patients and apply nanotechnology to analyze them and determine ...
... whose skulls were made whole again by bone tissue ... Healing critical-size defects (defects that would not otherwise heal ... type that forms the skull, is a vivid demonstration ... University to use hESCs for tissue regeneration. ...
Cached Biology News:Lupus gene finding prompts call for more DNA samples 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 3Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 4Human embryonic stem cell -- derived bone tissue closes massive skull injury 2
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
(Date:6/18/2013)... Though health care jobs continued to ... Bureau of Labor Statistics -- the increase was far below ... new health care jobs were added in home health care ... of 6,000 jobs. Overall, the U.S. unemployment rate stayed flat ... Christmas reported that a total of just over 36,000 job ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3
... The American Chamber of Commerce in Spain (AmChamSpain) ... Victor Grifols Roura, as the winner of its ... to recognize the international efforts of business leaders, ... responsible economic globalization. (Logo: http://photos.prnewswire.com/prnh/20110304/PH59473LOGO) ...
... -- Using minute graphite particles 1000 times smaller than the ... University hope to boost the efficiencyand profitabilityof solar power plants. ... more on rooftops, but they,re not necessarily the best solar ... they can use only a fraction of the sunlight that ...
... 2011 Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) ... preliminary assessment of the initial cohort of Tardive Dyskinesia ... (VMAT2), NBI-98854. Based on this data, the Company is ... the U.S. Food and Drug Administration (FDA). ...
Cached Biology Technology:The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols 2The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols 3Nanoparticles improve solar collection efficiency 2Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 2Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 3Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 4
All serum is collected from U.S.D.A. fryers and broilers. Pricing: $15/unit for 1 - 10 units; $12/unit for 11 - 50 units...
...
Whole blood is collected from healthy pigs (mixed breed, either sex) at the time of slaughter, refrigerated within 6 hours, processed within 24 hours and frozen at -20ºC....
ANTI S. ENT TOX BC2D...
Biology Products: